ZBIO Investors Have Opportunity to Lead Zenas BioPharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit againstZenas BioPharma, Inc. (“Zenas” or “the Company”) (NASDAQ: ZBIO) for violations of the federal securities laws. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents issued in connection with its initial […]